Patents-Review.com
🔗 Permalink
Assignee profile:

PharmaIN Corporation

City:

Bothell, Washington

Country:

United States

Published Applications:

14

Last publication date:

2023-08-10

Patent Grants:

12

Last grant date:

2025-09-09

Top Inventors for applications by PharmaIN Corporation

These are the the leading inventors for applications assigned to PharmaIN Corporation:

Recent patent applications by PharmaIN Corporation

PharmaIN Corporation based in Bothell, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-08-10 ✅ Patent 12,410,211 granted on 2025-09-09
US20230248800A1
Human necessities

V1A Receptor Partial Agonist and Method of Use

 #2 | 2020-08-13
US20200254100A1
Human necessities

ANIONIC-CORE COMPOSITION FOR DELIVERY OF THERAPEUTIC AGENTS, AND METHODS OF MAKING AND USING THE SAME

 #3 | 2020-01-16
US20200017567A1
Chemistry; metallurgy

NPRA AGONISTS, COMPOSITIONS, AND USES THEREOF

 #4 | 2018-11-01 ✅ Patent 10,882,961 granted on 2021-01-05
US20180312642A1
Chemistry; metallurgy

Method of production of graft co-polymer excipient with a superior peptide and protein binding property

 #5 | 2018-10-04 ✅ Patent 10,624,966 granted on 2020-04-21
US20180280516A1
Human necessities

Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same

 #6 | 2017-12-28 ✅ Patent 10,507,248 granted on 2019-12-17
US20170368190A1
Human necessities

Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same

 #7 | 2016-12-15 ✅ Patent 10,035,885 granted on 2018-07-31
US20160362523A1
Chemistry; metallurgy

Method of production of graft co-polymer excipient with a superior peptide and protein binding property

 #8 | 2015-10-29 ✅ Patent 9,657,078 granted on 2017-05-23
US20150307578A1
Chemistry; metallurgy

Composition for long-acting peptide analogs

 #9 | 2015-10-08 ✅ Patent 9,562,111 granted on 2017-02-07
US20150284476A1
Chemistry; metallurgy

Soluble hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same

 #10 | 2014-06-05 ✅ Patent 9,737,615 granted on 2017-08-22
US20140154203A1
Human necessities

Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same

 #11 | 2014-02-20 ✅ Patent 9,090,664 granted on 2015-07-28
US20140051628A1
Chemistry; metallurgy

Composition for long-acting peptide analogs

 #12 | 2012-07-26 ✅ Patent 10,010,613 granted on 2018-07-03
US20120190097A1
Human necessities

Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same

 #13 | 2010-09-16 ✅ Patent 8,999,930 granted on 2015-04-07
US20100234279A1
Chemistry; metallurgy

Soluble hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same

 #14 | 2009-02-26 ✅ Patent 8,563,527 granted on 2013-10-22
US20090053169A1
Human necessities

Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same

Also check out PharmaIn Corporation's (Bothell, United States) applicant profile with 9 patent applications submitted.

AssigneeID:

66952 ⎘